Florida Senate - 2021                                    SB 1612
       
       
        
       By Senator Rodriguez
       
       
       
       
       
       39-01348-21                                           20211612__
    1                        A bill to be entitled                      
    2         An act relating to prescription drug coverage;
    3         creating s. 627.42394, F.S.; requiring individual and
    4         group health insurers to provide notice of
    5         prescription drug formulary changes to current and
    6         prospective insureds and the insureds’ treating
    7         physicians; specifying the timeframe and manner in
    8         which such notice must be provided; specifying
    9         requirements for a notice of medical necessity
   10         submitted by the treating physician; authorizing
   11         insurers to provide certain means for submitting the
   12         notice of medical necessity; requiring the Financial
   13         Services Commission to adopt a certain form by rule by
   14         a specified date; specifying a coverage requirement
   15         and restrictions on coverage modification by insurers
   16         receiving such notice; providing construction and
   17         applicability; requiring insurers to maintain a record
   18         of formulary changes; requiring insurers to annually
   19         submit a specified report to the Office of Insurance
   20         Regulation; requiring the office to annually compile
   21         certain data, prepare a report and make the report
   22         publicly accessible on its website, and submit the
   23         report to the Governor and the Legislature; amending
   24         s. 627.6699, F.S.; requiring small employer carriers
   25         to comply with certain requirements for prescription
   26         drug formulary changes; amending s. 641.31, F.S.;
   27         providing an exception; requiring health maintenance
   28         organizations to provide notice of prescription drug
   29         formulary changes to current and prospective
   30         subscribers and the subscribers’ treating physicians;
   31         specifying the timeframe and manner in which such
   32         notice must be provided; specifying requirements for a
   33         notice of medical necessity submitted by the treating
   34         physician; authorizing health maintenance
   35         organizations to provide certain means for submitting
   36         the notice of medical necessity; requiring the
   37         commission to adopt a certain form by rule by a
   38         specified date; specifying a coverage requirement and
   39         restrictions on coverage modification by health
   40         maintenance organizations receiving such notice;
   41         providing construction and applicability; requiring
   42         health maintenance organizations to maintain a record
   43         of formulary changes; requiring health maintenance
   44         organizations to annually submit a specified report to
   45         the office; requiring the office to annually compile
   46         certain data, prepare a report and make the report
   47         publicly accessible on its website, and submit the
   48         report to the Governor and the Legislature; providing
   49         applicability; providing a declaration of important
   50         state interest; providing an effective date.
   51          
   52  Be It Enacted by the Legislature of the State of Florida:
   53  
   54         Section 1. Section 627.42394, Florida Statutes, is created
   55  to read:
   56         627.42394Health insurance policies; changes to
   57  prescription drug formularies; requirements.—
   58         (1)At least 60 days before the effective date of any
   59  change to a prescription drug formulary during a policy year, an
   60  insurer issuing individual or group health insurance policies in
   61  this state shall notify:
   62         (a)Current and prospective insureds of the change in the
   63  formulary in a readily accessible format on the insurer’s
   64  website; and
   65         (b)Electronically and by first-class mail, any insured
   66  currently receiving coverage for a prescription drug for which
   67  the formulary change modifies coverage and the insured’s
   68  treating physician. Such notification must include information
   69  on the specific drugs involved and a statement that the
   70  submission of a notice of medical necessity by the insured’s
   71  treating physician to the insurer at least 30 days before the
   72  effective date of the formulary change will result in
   73  continuation of coverage at the existing level.
   74         (2)The notice provided by the treating physician to the
   75  insurer must include a completed one-page form in which the
   76  treating physician certifies to the insurer that the
   77  prescription drug for the insured is medically necessary as
   78  defined under s. 627.732(2). The treating physician shall submit
   79  the notice electronically or by first-class mail. The insurer
   80  may provide the treating physician with access to an electronic
   81  portal through which the treating physician may electronically
   82  submit the notice. By January 1, 2022, the commission shall
   83  adopt by rule a form for the notice.
   84         (3)If the treating physician certifies to the insurer in
   85  accordance with subsection (2) that the prescription drug is
   86  medically necessary for the insured, the insurer:
   87         (a)Must authorize coverage for the prescribed drug until
   88  the end of the policy year, based solely on the treating
   89  physician’s certification that the drug is medically necessary;
   90  and
   91         (b)May not modify the coverage related to the covered drug
   92  during the policy year by:
   93         1.Increasing the out-of-pocket costs for the covered drug;
   94         2.Moving the covered drug to a more restrictive tier;
   95         3.Denying an insured coverage of the drug for which the
   96  insured has been previously approved for coverage by the
   97  insurer; or
   98         4.Limiting or reducing coverage of the drug in any other
   99  way, including subjecting it to a new prior authorization or
  100  step therapy requirement.
  101         (4)Subsections (1), (2), and (3) do not:
  102         (a) Prohibit the addition of prescription drugs to the list
  103  of drugs covered under the policy during the policy year.
  104         (b)Apply to a grandfathered health plan as defined in s.
  105  627.402 or to benefits specified in s. 627.6513(1)-(14).
  106         (c)Alter or amend s. 465.025, which provides conditions
  107  under which a pharmacist may substitute a generically equivalent
  108  drug product for a brand name drug product.
  109         (d)Alter or amend s. 465.0252, which provides conditions
  110  under which a pharmacist may dispense a substitute biological
  111  product for the prescribed biological product.
  112         (e) Apply to a Medicaid managed care plan under part IV of
  113  chapter 409.
  114         (5) A health insurer shall maintain a record of any change
  115  in its formulary during a calendar year. By March 1 annually, a
  116  health insurer shall submit to the office a report delineating
  117  such changes made in the previous calendar year. The annual
  118  report must include, at a minimum:
  119         (a) A list of all drugs that were removed from the
  120  formulary and the reasons for the removal;
  121         (b) A list of all drugs that were moved to a tier resulting
  122  in additional out-of-pocket costs to insureds;
  123         (c) The number of insureds notified by the insurer of a
  124  change in the formulary; and
  125         (d) The increased cost, by dollar amount, incurred by
  126  insureds because of such change in the formulary.
  127         (6) By May 1 annually, the office shall:
  128         (a) Compile the data in such annual reports submitted by
  129  health insurers and prepare a report summarizing the data
  130  submitted;
  131         (b) Make the report publicly accessible on its website; and
  132         (c) Submit the report to the Governor, the President of the
  133  Senate, and the Speaker of the House of Representatives.
  134         Section 2. Paragraph (e) of subsection (5) of section
  135  627.6699, Florida Statutes, is amended to read:
  136         627.6699 Employee Health Care Access Act.—
  137         (5) AVAILABILITY OF COVERAGE.—
  138         (e) All health benefit plans issued under this section must
  139  comply with the following conditions:
  140         1. For employers who have fewer than two employees, a late
  141  enrollee may be excluded from coverage for no longer than 24
  142  months if he or she was not covered by creditable coverage
  143  continually to a date not more than 63 days before the effective
  144  date of his or her new coverage.
  145         2. Any requirement used by a small employer carrier in
  146  determining whether to provide coverage to a small employer
  147  group, including requirements for minimum participation of
  148  eligible employees and minimum employer contributions, must be
  149  applied uniformly among all small employer groups having the
  150  same number of eligible employees applying for coverage or
  151  receiving coverage from the small employer carrier, except that
  152  a small employer carrier that participates in, administers, or
  153  issues health benefits pursuant to s. 381.0406 which do not
  154  include a preexisting condition exclusion may require as a
  155  condition of offering such benefits that the employer has had no
  156  health insurance coverage for its employees for a period of at
  157  least 6 months. A small employer carrier may vary application of
  158  minimum participation requirements and minimum employer
  159  contribution requirements only by the size of the small employer
  160  group.
  161         3. In applying minimum participation requirements with
  162  respect to a small employer, a small employer carrier shall not
  163  consider as an eligible employee employees or dependents who
  164  have qualifying existing coverage in an employer-based group
  165  insurance plan or an ERISA qualified self-insurance plan in
  166  determining whether the applicable percentage of participation
  167  is met. However, a small employer carrier may count eligible
  168  employees and dependents who have coverage under another health
  169  plan that is sponsored by that employer.
  170         4. A small employer carrier shall not increase any
  171  requirement for minimum employee participation or any
  172  requirement for minimum employer contribution applicable to a
  173  small employer at any time after the small employer has been
  174  accepted for coverage, unless the employer size has changed, in
  175  which case the small employer carrier may apply the requirements
  176  that are applicable to the new group size.
  177         5. If a small employer carrier offers coverage to a small
  178  employer, it must offer coverage to all the small employer’s
  179  eligible employees and their dependents. A small employer
  180  carrier may not offer coverage limited to certain persons in a
  181  group or to part of a group, except with respect to late
  182  enrollees.
  183         6. A small employer carrier may not modify any health
  184  benefit plan issued to a small employer with respect to a small
  185  employer or any eligible employee or dependent through riders,
  186  endorsements, or otherwise to restrict or exclude coverage for
  187  certain diseases or medical conditions otherwise covered by the
  188  health benefit plan.
  189         7. An initial enrollment period of at least 30 days must be
  190  provided. An annual 30-day open enrollment period must be
  191  offered to each small employer’s eligible employees and their
  192  dependents. A small employer carrier must provide special
  193  enrollment periods as required by s. 627.65615.
  194         8. A small employer carrier shall comply with s. 627.42394
  195  for any change to a prescription drug formulary.
  196         Section 3. Subsection (36) of section 641.31, Florida
  197  Statutes, is amended to read:
  198         641.31 Health maintenance contracts.—
  199         (36) Except as provided in paragraphs (a), (b), and (c), a
  200  health maintenance organization may increase the copayment for
  201  any benefit, or delete, amend, or limit any of the benefits to
  202  which a subscriber is entitled under the group contract only,
  203  upon written notice to the contract holder at least 45 days in
  204  advance of the time of coverage renewal. The health maintenance
  205  organization may amend the contract with the contract holder,
  206  with such amendment to be effective immediately at the time of
  207  coverage renewal. The written notice to the contract holder must
  208  shall specifically identify any deletions, amendments, or
  209  limitations to any of the benefits provided in the group
  210  contract during the current contract period which will be
  211  included in the group contract upon renewal. This subsection
  212  does not apply to any increases in benefits. The 45-day notice
  213  requirement does shall not apply if benefits are amended,
  214  deleted, or limited at the request of the contract holder.
  215         (a) At least 60 days before the effective date of any
  216  change to a prescription drug formulary during a contract year,
  217  a health maintenance organization shall notify:
  218         1.Current and prospective subscribers of the change in the
  219  formulary in a readily accessible format on the health
  220  maintenance organization’s website; and
  221         2.Electronically and by first-class mail, any subscriber
  222  currently receiving coverage for a prescription drug for which
  223  the formulary change modifies coverage and the subscriber’s
  224  treating physician. Such notification must include information
  225  on the specific drugs involved and a statement that the
  226  submission of a notice of medical necessity by the subscriber’s
  227  treating physician to the health maintenance organization at
  228  least 30 days before the effective date of the formulary change
  229  will result in continuation of coverage at the existing level.
  230         (b)The notice provided by the treating physician to the
  231  health maintenance organization must include a completed one
  232  page form in which the treating physician certifies to the
  233  health maintenance organization that the prescription drug for
  234  the subscriber is medically necessary as defined under s.
  235  627.732(2). The treating physician shall submit the notice
  236  electronically or by first-class mail. The health maintenance
  237  organization may provide the treating physician with access to
  238  an electronic portal through which the treating physician may
  239  electronically submit the notice. By January 1, 2022, the
  240  commission shall adopt by rule a form for the notice.
  241         (c)If the treating physician certifies to the health
  242  maintenance organization in accordance with paragraph (b) that
  243  the prescription drug is medically necessary for the subscriber,
  244  the health maintenance organization:
  245         1.Must authorize coverage for the prescribed drug until
  246  the end of the contract year, based solely on the treating
  247  physician’s certification that the drug is medically necessary;
  248  and
  249         2.May not modify the coverage related to the covered drug
  250  during the contract year by:
  251         a.Increasing the out-of-pocket costs for the covered drug;
  252         b.Moving the covered drug to a more restrictive tier;
  253         c.Denying a subscriber coverage of the drug for which the
  254  subscriber has been previously approved for coverage by the
  255  health maintenance organization; or
  256         d.Limiting or reducing coverage of the drug in any other
  257  way, including subjecting it to a new prior authorization or
  258  step therapy requirement.
  259         (d)Paragraphs (a), (b), and (c) do not:
  260         1. Prohibit the addition of prescription drugs to the list
  261  of drugs covered under the contract during the contract year.
  262         2. Apply to a grandfathered health plan as defined in s.
  263  627.402 or to benefits specified in s. 627.6513(1)-(14).
  264         3. Alter or amend s. 465.025, which provides conditions
  265  under which a pharmacist may substitute a generically equivalent
  266  drug product for a brand name drug product.
  267         4. Alter or amend s. 465.0252, which provides conditions
  268  under which a pharmacist may dispense a substitute biological
  269  product for the prescribed biological product.
  270         5. Apply to a Medicaid managed care plan under part IV of
  271  chapter 409.
  272         (e) A health maintenance organization shall maintain a
  273  record of any change in its formulary during a calendar year. By
  274  March 1 annually, a health maintenance organization shall submit
  275  to the office a report delineating such changes made in the
  276  previous calendar year. The annual report must include, at a
  277  minimum:
  278         1. A list of all drugs that were removed from the formulary
  279  and the reasons for the removal;
  280         2. A list of all drugs that were moved to a tier resulting
  281  in additional out-of-pocket costs to subscribers;
  282         3. The number of subscribers notified by the health
  283  maintenance organization of a change in the formulary; and
  284         4. The increased cost, by dollar amount, incurred by
  285  subscribers because of such change in the formulary.
  286         (f) By May 1 annually, the office shall:
  287         1. Compile the data in such annual reports submitted by
  288  health maintenance organizations and prepare a report
  289  summarizing the data submitted;
  290         2. Make the report publicly accessible on its website; and
  291         3. Submit the report to the Governor, the President of the
  292  Senate, and the Speaker of the House of Representatives.
  293         Section 4. This act applies to health insurance policies,
  294  health benefit plans, and health maintenance contracts entered
  295  into or renewed on or after January 1, 2022.
  296         Section 5. The Legislature finds that this act fulfills an
  297  important state interest.
  298         Section 6. This act shall take effect January 1, 2022.